| Bladder and Urothelial Cancer Treatments | Lifetime | 67 | FR 2 | 99.61 |
| Urinary and Genital Oncology Studies | Lifetime | 41 | FR 2 | 99.61 |
| Renal cell carcinoma treatment | Lifetime | 257 | FR 11 | 98.74 |
| Epigenetics and DNA Methylation | Lifetime | 689 | FR 11 | 98.39 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 685 | FR 51 | 98.51 |
| Genetic factors in colorectal cancer | Lifetime | 539 | FR 15 | 98.15 |
| Urological Disorders and Treatments | Lifetime | 532 | FR 12 | 97.98 |
| Renal and related cancers | Lifetime | 470 | FR 14 | 97.80 |
| Chromatin Remodeling and Cancer | Lifetime | 133 | FR 9 | 96.05 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 592 | FR 32 | 97.01 |
| Sarcoma Diagnosis and Treatment | Lifetime | 941 | FR 54 | 97.02 |
| Soft tissue tumor case studies | Lifetime | 233 | FR 10 | 96.87 |
| Fibroblast Growth Factor Research | Lifetime | 288 | FR 15 | 95.86 |
| Ferroptosis and cancer prognosis | Lifetime | 685 | FR 14 | 93.90 |
| Cancer Mechanisms and Therapy | Lifetime | 486 | FR 21 | 95.29 |
| Tumors and Oncological Cases | Lifetime | 460 | FR 21 | 96.07 |
| Multiple and Secondary Primary Cancers | Lifetime | 953 | FR 77 | 91.60 |
| Infectious Disease Case Reports and Treatments | Lifetime | 511 | FR 24 | 73.61 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 200 | FR 12 | 97.46 |
| Renal and related cancers | 2021-2025 | 115 | FR 6 | 96.28 |
| Renal cell carcinoma treatment | 2021-2025 | 197 | FR 14 | 96.75 |
| Cancer Genomics and Diagnostics | 2021-2025 | 751 | FR 27 | 95.51 |
| Urinary and Genital Oncology Studies | 2021-2025 | 266 | FR 18 | 93.52 |
| Genetic factors in colorectal cancer | 2021-2025 | 854 | FR 43 | 87.24 |
| Tumors and Oncological Cases | 2021-2025 | 189 | FR 18 | 83.92 |
| Urological Disorders and Treatments | 2021-2025 | 806 | FR 41 | 84.65 |
| Genital Health and Disease | 2021-2025 | 398 | FR 6 | 83.20 |
| Chromatin Remodeling and Cancer | 2021-2025 | 322 | FR 9 | 73.82 |
| Cancer Mechanisms and Therapy | 2021-2025 | 793 | FR 17 | 74.22 |
| Ear and Head Tumors | 2021-2025 | 841 | FR 30 | 64.52 |
| Soft tissue tumor case studies | 2021-2025 | 697 | FR 61 | 52.88 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 948 | FR 36 | 22.27 |